NewsBenzinga오펜하이머, 세바에 대한 ‘시장수익률 상회’ 의견 재확인···목표주가 35달러로 하향 조정 오펜하이머, 세바에 대한 ‘시장수익률 상회’ 의견 재확인···목표주가 35달러로 하향 조정 Benzinga 2026.11.10 16:43 (GMT+0) Open on Benzinga Other news Canaccord Genuity Maintains Buy on Belite Bio, Raises Price Target to $314 Applied Optoelectronics Stock Sinks Amid AI Outlook Fears Canaccord Genuity Maintains Buy on Enovix, Lowers Price Target to $2.5 Canaccord Genuity Maintains Buy on Intuitive Machines, Lowers Price Target to $38 'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report Canaccord Genuity Maintains Buy on Nektar Therapeutics, Lowers Price Target to $149
'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report